Managing director Evan Norton has stepped down from Abbott Ventures after leading the unit’s investment initiatives for nearly a decade, moving to Accelmed.

MIT-founded genomic data analytics spinout BC Platforms raised the cash in a series C round led by newly minted strategic partner Iqvia.

Medipal and Sony Innovation Fund by IGV were among the investors that boosted the liver disease drug developer's latest round to $52.6m.

Lenskart will exit the vision-testing app developer in an acquisition expected to be around the $100m mark, two years after investing $1m.

Genetic disease drug developer Triplet Therapeutics has emerged from stealth with $59m including $49m in a round co-led by Pfizer Ventures.

Guangxi Royal Dairy committed nearly half the capital for the venture firm's latest fund, which has closed at $86.7m.

CU Boulder spinout Inscripta has now accumulated more than $259m from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cigna Ventures led a round disclosed by the musculoskeletal recovery services provider as it rebrands from Trainer Rx.

The digital health engagement platform, which counts Samsung and Rakuten as existing investors, has completed a series C round of undisclosed size.